Global Blood Therapeutics

171 Oyster Point Blvd., Suite 300
South San Francisco
United States


Show jobs for this employer

About Global Blood Therapeutics

GBT is a biopharmaceutical company determined to discover, develop and deliver innovative treatments that provide hope to underserved patient communities. GBT is developing two therapies for the potential treatment of sickle cell disease, including its late-stage product candidate, voxelotor, as an oral, once-daily therapy. To learn more, please visit and follow the company on Twitter @GBT_news.

132 articles with Global Blood Therapeutics